Close
Who We Are
Leadership Team
Board of Directors
Environmental, Social, and Governance (ESG) Commitment
Justice, Equity, Diversity, and Inclusion Commitment
Our Platform
Posters & Publications
Our Pipeline
Inflammatory Diseases
Patients, Families & Physicians
Investors & Media
News & Events
SEC Filings
Stock
Analyst Coverage
Governance
Careers
Contact Us
Skip to main content
Skip to footer
Evelo
Menu
Monoclonal microbial EDP1503 induces antitumor responses via gut-mediated activation of both innate and adaptive immunity
Home
/
Posters
/
Monoclonal microbial EDP1503 induces antitumor responses via gut-mediated activation of both innate and adaptive immunity
November 11, 2019
by
